seekingalpha.com
Cibus, Inc. (CBUS) Q4 2025 Earnings Call Transcript
Cibus, Inc. (CBUS) Q4 2025 Earnings Call Transcript
Cibus, Inc.CBUSNASDAQ
Loading
Latest News
zacks.com
Cibus (CBUS) Reports Q4 Loss, Lags Revenue Estimates
Cibus (CBUS) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to a loss of $0.87 per share a year ago.
globenewswire.com
Cibus Reports Fourth Quarter Financial Results and Provides Business Update
SAN DIEGO, March 17, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the "Company"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced its financial results for the quarter ended December 31, 2025, and provided a business update. Management will host a conference call and webcast today at 4:30 p.m. ET.
globenewswire.com
Cibus to Report Fourth Quarter 2025 Financial Results on March 17, 2026 After the Market Close and Host Conference Call
SAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the company will report fourth quarter 2025 financial results on Tuesday, March 17, 2026. Cibus' management team will host a conference call and audio webcast at 4:30 p.m.
globenewswire.com
Cibus Partnering with The John Innes Centre for UK Government's Farming Innovation Programme Precision Breeding Initiative
Cibus to utilize proprietary Rapid Trait Development System™ to enable development of durable resistance to Light Leaf Spot disease, which has caused estimated yield losses of up to £300m in recent years
globenewswire.com
Cibus, Inc. Announces Pricing of $20.0 Million Public Offering of Class A Common Stock
SAN DIEGO, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced the pricing of an underwritten public offering of 13,333,333 shares of its Class A Common Stock, par value $0.0001 per share (“Class A Common Stock”), at a public offering price of $1.50 per share (the “Offering”). Members of Cibus' Board of Directors will purchase 1,000,000 shares of Class A Common Stock in the Offering at the public offering price.
globenewswire.com
Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock
SAN DIEGO, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that it intends to offer shares of its Class A common stock, par value $0.0001 per share (“Class A Common Stock”), in an underwritten public offering (the “Offering”). Cibus also expects to grant to the underwriter of the Offering a 30-day option to purchase up to an additional 15% of the shares of Class A Common Stock offered in the Offering on the same terms and conditions. The Offering is subject to market and other conditions, and there can be no assurance as to whether or when the Offering may be completed or as to the actual size or terms of the Offering. Members of Cibus' Board of Directors (collectively, the “Related Persons”) have indicated an interest in purchasing shares of Class A Common Stock in the Offering. Because these indications of interest are not binding agreements or commitments to purchase, those certain Related Persons may elect not to purchase any shares in the Offering, or the underwriter may elect not to sell any shares in the Offering to those certain Related Persons.
globenewswire.com
Cibus and Interoc Advance Rice Commercialization Strategy for Herbicide-Tolerant Traits in Key Markets across Latin America
Nonbinding Letter of Intent (LOI) sets framework for potential 2027 market entry in Ecuador and Colombia, followed by expansion into Peru, Central America and the Caribbean Expected to build on success under the existing 2024 material transfer agreement, shifting focus to market execution and revenue generation for co-developed herbicide-tolerant (HT) rice traits SAN DIEGO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, and Interoc, a leading provider of agricultural solutions in Latin America, today announced the execution of a non-binding Letter of Intent (LOI). The non-binding LOI establishes a potential framework for the commercialization of co-developed herbicide-tolerant (HT) rice traits in key rice-producing markets across Latin America.
globenewswire.com
Cibus Welcomes the Positive Conclusion of Trilogue Negotiations on New Genomic Techniques Legislation Between the European Parliament and Council
Political agreement on New Genomic Techniques (NGTs), including gene editing, advances a science-based path for plant breeding innovation and supports Cibus' plans to bring improved traits to European growers
seekingalpha.com
Cibus, Inc. (CBUS) Q3 2025 Earnings Call Transcript
Cibus, Inc. ( CBUS ) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants Carlo Broos - Chief Financial Officer Peter Beetham - Co-Founder, Interim CEO, President, COO & Director Gregory Gocal - Co-Founder, Chief Scientific Officer & Executive VP Conference Call Participants Kevin Estok - Jefferies LLC, Research Division Matthew Venezia - Alliance Global Partners, Research Division Sameer Joshi - H.C. Wainwright & Co, LLC, Research Division Austin Moeller - Canaccord Genuity Corp., Research Division Alex Hantman - Sidoti & Company, LLC Presentation Operator Good afternoon, everyone, and welcome to the Cibus Third Quarter 2025 Results Conference Call.
zacks.com
Cibus (CBUS) Reports Q3 Loss, Misses Revenue Estimates
Cibus (CBUS) came out with a quarterly loss of $0.44 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to earnings of $0.06 per share a year ago.
globenewswire.com
Cibus Reports Third Quarter Financial Results and Provides Year-to-Date Business Update for 2025
With the addition of Centro Internacional de Agricultura Tropical (CIAT) in the quarter, Cibus now has 5 LATAM Rice customers as momentum continues toward achieving 2027 targeted initial LATAM Rice revenue On track to deliver HT traits to Latin American customer in Q4 2025 with field trials expected to commence by year end Engaged strategic growth advisory firm AgVayā to introduce Indian Rice growers to new solutions to scale crop productivity through advanced gene editing Su ccessfully completed pre-commercial pilot runs for certain biofragrance products; commercial expansion targeted for 2026 Positive field trial results for HT2 in Canola in North America ; HT2 and Sclerotinia resistance traits available for seed licensing partners for funded continued development opportunity Initiated additional actions to support streamlined business focus prioritizing nearest-term and partner-funded commercial opportunities while the Company targets a reduced annual net cash usage of $30 million by 2026, and completed consolidation of Oberlin facility activities Appointed Kimberly A. Box and Craig Wichner to Cibus' Board of Directors, which strategically strengthens Cibus' commercial expansion support SAN DIEGO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the "Company"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced its financial results for the quarter ended September 30, 2025, and provided a year-to-date business update for 2025.
globenewswire.com
Cibus Announces the Election of Craig Wichner to Board of Directors
Appointment underscores company's commitment to long-term shareholder value creation and sustained business growth Appointment underscores company's commitment to long-term shareholder value creation and sustained business growth
globenewswire.com
Cibus to Report Third Quarter 2025 Financial Results on November 13, 2025 After the Market Close and Host Conference Call
SAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the company will report third quarter 2025 financial results on Thursday, November 13, 2025. Cibus' management team will host a conference call and audio webcast at 4:30 p.m.
globenewswire.com
Cibus and AgVayā Collaborate to Introduce Indian Rice Growers to New Solutions to Scale Crop Productivity Through Advanced Gene Editing
Collaboration aims to accelerate the adoption of advanced gene editing technologies in and deliver high-performance traits that support more sustainable and productive rice production in India Collaboration aims to accelerate the adoption of advanced gene editing technologies in and deliver high-performance traits that support more sustainable and productive rice production in India
globenewswire.com
Cibus Announces Positive Field Trial Results for Second-Generation Herbicide Tolerance (HT2) Edited Canola
Field testing confirms efficacy of HT2 trait in Canola under real-world conditions HT2 trait will be offered to potential seed licensing partners for introduction into commercial Canola seed products SAN DIEGO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company”), a leading agricultural technology company developing and licensing advanced gene edited plant traits that enable improved productivity, higher yields, lower input costs, and more sustainable farming, today announced the completion of field testing for its second-generation herbicide tolerance (HT2) edited Canola with positive results. “Our second-generation herbicide tolerance edited canola previously performed well in greenhouse trials and has now shown positive results in our 2025 Canola field trials,” said Jim Radtke, PhD, Senior VP of Product Development at Cibus.
globenewswire.com
Cibus Announces the Election of Kimberly A. Box to Board of Directors
Appointment strengthens governance and commercialization strategy expertise as Cibus continues preparations for launch of its advanced trait technologies delivering crop productivity and sustainability solutions to farmers Appointment strengthens governance and commercialization strategy expertise as Cibus continues preparations for launch of its advanced trait technologies delivering crop productivity and sustainability solutions to farmers
globenewswire.com
Cibus CEO to Highlight Gene Editing's Role in Building Resilient Agriculture at UN Climate Week 2025
SAN DIEGO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company specializing in the development and licensing of gene-edited plant traits, today announced that Peter Beetham, Co-Founder, President, and Interim Chief Executive Officer, will participate in a featured panel during UN Climate Week 2025 in New York City.
globenewswire.com
Cibus Enters into Agreement with the Latin American Rice Hybrid Consortium to Provide Cibus' Herbicide Tolerance Trait
Cibus and Centro Internacional de Agricultura Tropical (CIAT) have entered into an agreement to introduce Cibus' proprietary herbicide tolerance trait into elite rice germplasm for Latin America Agreement represents another significant milestone as Cibus aims to bring Latin America rice growers new solutions for advanced weed management in Rice crops SAN DIEGO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company specializing in the development and licensing of gene-edited plant traits, today announced a material transfer agreement with Centro Internacional de Agricultura Tropical (CIAT), an organization which, in collaboration with the Latin American Fund for Irrigated Rice (FLAR), participates in the Hybrid Rice Consortium for Latin America (HIAAL) and is dedicated to the advancement of rice hybrids in Latin America. Through this agreement Cibus will provide its HT3 clethodim herbicide tolerance trait to be introduced into HIAAL's elite rice germplasm.